期刊文献+

乳腺癌组织中Ki67的表达及临床意义 被引量:10

The expression and clinical significance of Ki67 in breast cancer
下载PDF
导出
摘要 目的通过检测乳腺癌组织中Ki67的表达水平,探讨Ki67与各临床病理指标之间的关系及临床意义。方法收集河北医科大学第四医院乳腺外科原发性乳腺癌患者术后标本2390例,对Ki67与临床病理因素进行相关性分析。结果 Ki67与绝经情况无相关(P>0.05);与年龄、肿瘤大小、病理分期、病理类型、脉管瘤栓、组织分级、淋巴结转移、ER、PR、HER-2、Ki67、p53均有相关性(P<0.05)。结论 Ki67阳性表达可以作为判断乳腺癌生物学行为的重要指标。 Objective By means of the detection of expression levels of Ki67, to investigate the correlation between the expression of Ki67 and clinical pathological parameters as well as its clinical significance. Methods The 2 390 postoperative specimens of patients with primary breast cancer in Department of Breast Surgery,The Fourth Hospital of Hebei Medical University were collected from January 1,2009 to December 31, 2010. The correlation between Ki67 and clinical pathological factors was analyzed. Results The expression levels of Ki67 were not related with menostasia ( P 〉 0. 05 ) , however, which were correlated to patients' age, tumor' s size, pathological stage, pathological type, vascular tumor thrombus, pathological grade, lymph node metastasis, ER, PR, HER-2,p53 ( P 〈 0.05 ). Conclusion The positive expression of Ki67 can be regarded as an important index for evaluating biological behavior of breast cancer.
出处 《河北医药》 CAS 2013年第12期1769-1771,共3页 Hebei Medical Journal
关键词 乳腺肿瘤 KI67 病理学 breast neoplasm Ki67 pathology
  • 相关文献

参考文献10

  • 1徐菁,李士瑛,兰向昀.环氧化酶-2、c-erbB-2和Ki67在结直肠癌中表达及其临床意义[J].解剖学杂志,2005,28(3):287-289. 被引量:6
  • 2Gigerenzer G,Mata J,Frank R. Public knowledge of benefits of breast andprostate cancer screening in Europe. J Natl Cancer Inst ,2009,101:1216-1220.
  • 3徐光炜,胡永昇,阚秀.中国10万妇女乳腺癌筛查初探[J].中国肿瘤,2010,19(9):565-568. 被引量:64
  • 4Gerdes J,Lemke H,Baisch H,et al. Cell cycle analysis of a cell prolifera-tion-associated human nuclear antigen defined by the monoclonal antibod-y Ki67. J Immunol, 1984,133 : 1710-1715.
  • 5Bhatavdekar JM,Pateld D,Shah NG,et at. Prognostic significance of im-munohisto-chemically localized biomarkers in stage H and stage M breastcancer:a multivariate analysis. Ann Surg Oncol,2000,7:305-311.
  • 6周才明,黎绍基,何健标.乳腺癌淋巴结转移与ER,PR,Ki67,P53表达的相关分析及临床意义.广东医药,2007,28:510-512.
  • 7Zellaxs RC, Hilsenbeck SG, Clark GM, et al. Prognostic VALUE of p53for local failure in mastectomy-treated breast cancer patients. Clin Oncol,2000,18:1906-1913.
  • 8Hobertson KW, Reeves JR, Smith G,et al. Quantitatire estimation of epi-dermal growth factor receptor and C-erbB-2 in human breast cancer.Cancer Res,1996,5 :3823-3830.
  • 9Montero S, Guzman C, Vargas C, et al. Prognostic value of cytosolic p53protein in breast cancer. Tumor Biol,2001,22:337-339.
  • 10Ringbreg A,Anagnostaki L,Anderson H,et al. Cell biological factors inductal carcinoma in siu ( DCIS) of the breast relationship to ipsilaterallocal recurrence and histopathological characteristics. Eur J Cancer,2001,37:1514-1522.

二级参考文献12

  • 1张思维,雷正龙,李光琳,邹小农,陈万青,赵平.中国肿瘤登记地区2005年发病死亡资料分析[J].中国肿瘤,2009,18(12):973-979. 被引量:32
  • 2Buchberger W, Dekoekkoek-Doll P, Springer P, et al. Incidental findings on sonography of the breast [J]. Am J Roentgenol, 1999, 173:921-927.
  • 3Stavros AT, Thickman D, Rapp CL, et al. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions [J]. Radiology, 1995, 196(1):123-134.
  • 4Mann M, Sheng H, Shao J, et al. Targeting cyclooxygenase-2 and HER2/neu pathways inhibits colorectal carcinoma growth. Gastroenterology, 2001,120(10):1713-1719.
  • 5Ratna V, Mahitosh M, Liana A, et al. Regulation of cyclooxygenase-2 pathway by HER2 receptor. Oncogene, 1999,18(2):305-314.
  • 6Appleby SB, Ristimaki A, Neilson T, et al. Structure of the human cyclooxygenase-2. Biochem J, 1994,302(13):723-727.
  • 7Mahony CA, Beauchamp RD, Albo D, et al. Cyclooxygenase-2 alters transforming growth factor beta 1 response during intestinal tumorigenesis. Surgery, 1999,26(6):364-370.
  • 8Tsujii M, Kawano S, Dubois RN, et al. Cyclooxygenase-2 expression in human colon cancer cells increases expression in human colon cancer cells incerases metastatic potential. Proc Natal Acad Sci USA, 1997,94(5):3336-3340.
  • 9Yang JL, Yu Y, Markovic B, et al. Overexpression of c-erbB-2 mRNA and/or c-neu oncoprotein is a predictor for metastases from colorectal cancer. Anticancer Res, 1997,17(2A):1023-1026.
  • 10Coffey RJ, Hawkey CJ, Damstrip L, et al. EGF receptor activation induces nuclear targeting of COX-2 basolateral release of prostaglandins and mitogenesis in polarizing colon cancer cells. Proc Natl Acad Sci USA, 1997,94(11):657-662.

共引文献68

同被引文献102

  • 1李宝江,朱志华,王军业,侯景辉,赵进明,张蓬原,姚广裕,王曦,龙浩,杨名添,戎铁.Ki67、P53、VEGF和C-erbB-2在乳腺癌组织中表达的相关性研究及其临床意义[J].癌症,2004,23(10):1176-1179. 被引量:126
  • 2皋岚湘,丁华野.免疫组织化学在乳腺疾病鉴别诊断中的应用[J].诊断病理学杂志,2006,13(1):8-12. 被引量:11
  • 3张丽华,孙荣超,陈瑛.乳腺浸润性微乳头状癌临床病理观察[J].诊断病理学杂志,2006,13(2):99-101. 被引量:5
  • 4MingLiu,GeorgesLawson,MoniqueDelos,JacquesJamart,ChristopheIde,EmmanuelCoche,BirgitWeynand,GauthierDesuter,MarcHamoir,MarcRemacle,EtienneMarbaix.Predictive value of the fraction of cancer cells immunolabeled for proliferating cell nuclear antigen or Ki67 in biopsies of head and neck carcinomas to identify lymph node metastasis: Comparison with clinical and radiologic examinations[J]. Head Neck . 2003 (4)
  • 5Dowsett M,Nielsen T O,A′Hern R,et al.Assessment of Ki67 in breast cancer:recommendations from the international Ki67 in breast cancer working group[J].J Natl Cancer Inst,2011,103(22):1656-64.
  • 6Tavassoli F A,Devilee P.World Health Orangnization classification of tumors.Pathology and female gentital organs[M].Lyon:IARC Press,2003:35-6.
  • 7LunaMoré S,de los Santos F,Bretón J J,Caadas M A.Estrogen and progesterone cerbB2,p53 and Bcl2 in thirtythree invasive micropapillary breast carcinoma[J].Pathol Res Pract,1996,192(1):27-32.
  • 8Bae Y K,Gong G,Kang J,et al.Hormone receptor expression in invasive breast cancer among Korean women and comparison of 3 antiestrogen receptor antibodies:a multiinstitutional retrospective study using tissue microarrays[J].Am J Surg Pathol,2012,36(12):1817-25.
  • 9Walsh M M,Bleiweiss I J.Invasive micropapillary carcinoma of the breast:eighty cases of an underrecognized entity[J].Hum Pathol,2001,32(6):583-9.
  • 10Vingiani A,Maisonneuve P,Dell'orto P,et al.The clinical relevance of micropapillary carcinoma of the breast:a casecontrol study[J].Histopathology,2013,63(2):217-24.

引证文献10

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部